Open access · CC-BY
via OpenAlex
Lactococcus garvieae FUA009, a Novel Intestinal Bacterium Capable of Producing the Bioactive Metabolite Urolithin A from Ellagic Acid
Haoyu Mi, Shu Liu, Yang Hai, Guang Yang, Jing Lu, Fuxiang He, Yaling Zhao, Mengjie Xia, Xiaoyue Hou, Yaowei Fang
Foods · 2022 · ▲ 34 citations
Abstract
Dietary polyphenol ellagic acid has anti-cancer and anti-inflammatory activities, and these biological activities require the conversion of ellagic acid to urolithins by intestinal microbes. However, few gut microbes are capable of metabolizing ellagic acid to produce urolithins, limiting the beneficial effects of ellagic acid on health. Here, we describe an intestinal bacterium Lactococcus garvieae FUA009 isolated from the feces of a healthy volunteer. It was demonstrated via HPLC and UPLC-MS analysis that the end product of ellagic acid metabolism of FUA009 was urolithin A. In addition, we also examined the whole genome sequence of FUA009 and then assessed the safety and probiotic properties of FUA009 based on a complete genome and phenotype analysis. We indicated that FUA009 was safe, which was confirmed by FUA009 being sensitive to multiple antibiotics, having no hemolytic activity, and being free of aggressive putative virulence factors. Moreover, 19 stress-responsive protein genes and 8 adhesion-related genes were predicted in the FUA009 genome. Furthermore, we demonstrated that FUA009 was tolerant to acid and bile salt by determining the cell viability in a stress environment. In summary, Lactococcus garvieae FUA009, as a novel UA-producing bacterium, not only contributes to the study of the metabolic pathway of ellagic acid but is also expected to be a novel probiotic candidate.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.3390/foods11172621
- Canonical
- link ↗
- Fetched
- 2026-11-01 MST
Cite this
APA
Mi, H., Liu, S., Hai, Y., Yang, G., Lu, J., He, F., Zhao, Y., Xia, M., Hou, X., & Fang, Y. (2022). Lactococcus garvieae FUA009, a Novel Intestinal Bacterium Capable of Producing the Bioactive Metabolite Urolithin A from Ellagic Acid. <em>Foods</em>. https://doi.org/10.3390/foods11172621
Vancouver
Mi H, Liu S, Hai Y, Yang G, Lu J, He F, et al. Lactococcus garvieae FUA009, a Novel Intestinal Bacterium Capable of Producing the Bioactive Metabolite Urolithin A from Ellagic Acid. Foods. 2022. doi:10.3390/foods11172621.
BibTeX
@article{haoyu2022Lactoc,
title = {Lactococcus garvieae FUA009, a Novel Intestinal Bacterium Capable of Producing the Bioactive Metabolite Urolithin A from Ellagic Acid},
author = {Haoyu Mi and Shu Liu and Yang Hai and Guang Yang and Jing Lu and Fuxiang He and Yaling Zhao and Mengjie Xia and Xiaoyue Hou and Yaowei Fang},
journal = {Foods},
year = {2022},
doi = {10.3390/foods11172621},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Foods 2022
Open access · CC-BY
A Novel Streptococcus thermophilus FUA329 Isolated from Human Breast Milk Capable of Producing Urolithin A from Ellagic Acid
American Journal of Physiology-Renal Physiology 2018
Open access · OA
The impact of preserved Klotho gene expression on antioxidative stress activity in healthy kidney
Biology of Reproduction 2015
Open access · OA
The Role of Placental 11-Beta Hydroxysteroid Dehydrogenase Type 1 and Type 2 Methylation on Gene Expression and Infant Birth Weight1
bioRxiv (Cold Spring Harbor Laboratory) 2025
Preprint · CC-BY
Coordinated shifts in gene expression and regulation during mole-rat evolution
University of Seville 2024
Open access · US-GOV
Evaluation and Development of the HUMANisation of CARE in the Andalusian Public Health System in Complex User Units and Hospital Emergency Units: Attention to Frailty, Prevention of Adverse Events, and the Impact of the Nurse-patient Relationship on Health Outcomes
Cell Stress and Chaperones 2017
Open access · CC-BY